← Back to Search

Spinal Cord Stimulation + Rehabilitation for Stroke (HARNESS Trial)

N/A
Recruiting
Led By Chet Moritz, PhD
Research Sponsored by University of Washington
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Upper Extremity Fugl-Meyer Assessment score "moderate" or "moderate-mild" (29-53 inclusive out of 66) at the screening visit
Radiologically documented single ischemic stroke resulted in hemiplegia/hemiparesis
Must not have
Taking baclofen more than 30 mg/day
Severe joint contractures in the affected hand and arm
Timeline
Screening 3 weeks
Treatment Varies
Follow Up "measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months."
Awards & highlights
No Placebo-Only Group

Summary

This trial seeks to find if non-invasive spinal stimulation combined with activity-based rehabilitation can improve hand and arm movement in people with a stroke.

Who is the study for?
This trial is for adults who had an ischemic stroke at least six months ago, with moderate to mild arm and hand movement difficulties. They must be medically stable, able to understand English, have social support for attending sessions thrice weekly, not pregnant or agree to use contraception, and have a single documented stroke causing one-sided weakness.
What is being tested?
The study tests if non-invasive electrical spinal cord stimulation combined with activity-based rehabilitation can improve hand and arm function after a stroke. It involves placing surface electrodes on the neck for stimulation and practicing functional tasks as part of rehabilitation.
What are the potential side effects?
Potential side effects may include discomfort at the electrode site, muscle fatigue from rehabilitation exercises, and possible skin irritation from the electrodes. The exact side effects will vary depending on individual tolerance to electrical stimulation.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
My arm and hand movement ability is moderately impaired.
Select...
I had a stroke that caused weakness or paralysis on one side of my body.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I take more than 30 mg of baclofen daily.
Select...
I have severe stiffness in my hand and arm joints.
Select...
I have significant memory or thinking problems.
Select...
I have had a bleeding stroke.
Select...
I have had more than one stroke.
Select...
I have severe muscle stiffness in my arm.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~"measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months."
This trial's timeline: 3 weeks for screening, Varies for treatment, and "measurements at baseline and repeated measurements once every two weeks throughout the study, an average of 8 months." for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Upper Extremity
Change from baseline - Modified Ashworth Scale
Change from baseline - Pinch and grip force
+1 more
Secondary study objectives
Change from baseline - Action Research Arm Test
Change from baseline - Box and Blocks Test
Change from baseline - H-reflex test
+6 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Non-invasive Electrical Spinal Cord Stimulation + Activity Based RehabilitationExperimental Treatment2 Interventions
Non-invasive electrical spinal cord stimulation will be performed using surface electrodes placed over the skin of the neck. Biphasic rectangular pulses of 1 millisecond per phase duration will be delivered with a 10 kiloHertz overlapping frequency and between 20-120 Hertzz burst frequency. Non-invasive electrical spinal cord stimulation will be paired with Activity Based Rehabilitation sessions. Stimulation plus rehabilitation sessions will be three times per week, 90 minutes per session for six weeks (total of 18 sessions).
Group II: Activity Based RehabilitationActive Control1 Intervention
Activity Based Rehabilitation is comprised of intensive, progressive, functional task practice. The protocol consists of repetitive activities of gross upper limb movement, isolated finger movements, bimanual task performance, simple and complex pinch, and grip performance. Several activities with various difficulty levels are designated for each category, and the participant will perform 1-2 activities within each category in each rehabilitation session. Rehabilitation sessions will be three times per week, 90 minutes per session for six weeks (total of 18 sessions).

Find a Location

Who is running the clinical trial?

University of WashingtonLead Sponsor
1,831 Previous Clinical Trials
1,907,563 Total Patients Enrolled
17 Trials studying Stroke
8,946 Patients Enrolled for Stroke
Chet Moritz, PhDPrincipal InvestigatorUniversity of Washington
1 Previous Clinical Trials
65 Total Patients Enrolled

Media Library

Activity Based Rehabilitation Clinical Trial Eligibility Overview. Trial Name: NCT05591196 — N/A
Stroke Research Study Groups: Activity Based Rehabilitation, Non-invasive Electrical Spinal Cord Stimulation + Activity Based Rehabilitation
Stroke Clinical Trial 2023: Activity Based Rehabilitation Highlights & Side Effects. Trial Name: NCT05591196 — N/A
Activity Based Rehabilitation 2023 Treatment Timeline for Medical Study. Trial Name: NCT05591196 — N/A
~2 spots leftby Dec 2025